NEW DEAL was rewarded at Mayoly’s Forum

PaulineInflammatory bowel diseases, Nanotherapy, New Deal

The Mayoly Management Forum took place from the 5th to the 8th of February, in Valence. The event gathered all the managers from Mayoly and at this occasion the New Deal project was presented. A new nanotherapy research for inflammatory bowel diseases The goal of the project NEW DEAL is to design and validate a new targeted therapy against inflammatory bowel diseases (IBDs). This … Read More

NEW DEAL at European Technology Plateform on Nanomedicine 2017

PaulineNanomedicine, Nanotherapy, New Deal

At the occasion of the 12th annual event of the European Technology Platform on Nanomedicine in Malaga, Spain, Dr Fabrice Navarro from CEA-LETI was invited to present New Deal as an innovative project in nanomedicine. Daniel Perez from Nanoimmunotech, another member of the consortium, was also present during this event. ETPN is the occasion to discuss current trends, to meet and … Read More

New EU project develops a highly selective and local therapy for Inflammatory Bowel Diseases

CarolineInflammatory bowel diseases, Nanotherapy, New Deal

The innovations introduced by NEW DEAL strengthen the leadership of Europe in the field of advanced therapies and in particular, in nanotherapies. An alternative therapy for inflamatory bowel diseases (IBDs) The goal of the new European project NEW DEAL is to design and validate a new targeted therapy against inflammatory bowel diseases (IBDs). This therapy is aimed at treating patients … Read More